Tscan Therapeutics, Inc. · NASDAQ:TCRX
BlackRock, Inc. reported a 5.40% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 24, 2025
BlackRock, Inc. reported a 5.40% stake in Tscan Therapeutics, Inc., 2,825,823 shares, as a passive investor on Mar 31, 2025. Filed Apr 24, 2025 (Schedule 13G/A).
- Stake
- 5.40%
- Shares
- 2,825,823
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.40% | 2,825,823 |
Source
Related
- Tscan Therapeutics, Inc.
- BlackRock, Inc.
- Tscan Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026